The Riverside Company sold Euromed, producer of herbal extracts and natural active substances for pharmaceutical, health, food, and cosmetic industries, to Dermapharm, a German pharmaceutical company. Financial terms were not disclosed. Riverside invested in the company back in 2015. “Euromed presented us with an exciting opportunity to expand its portfolio by adding new processes and best practices – especially as it relates to R&D and new product development,” said Riverside Partner Rafael Álvarez-Novoa. “We built a new R&D center at the Euromed headquarters with latest lab equipment to help implement a structured product development process, allowing the sales team to present customers with new opportunities, constantly seeking to develop innovative products and applications for the extracts that they already commercialize, and to develop new extracts.”